癌症标志物
癌症标志物又稱腫瘤標誌物,是由癌細胞直接产生或由非癌細胞经癌細胞诱导产生(人體對癌細胞的反應)的物质(生物標記)[1]。癌症标志物存在於人們的血液、尿液或组织中。对于肿瘤标志物的检测可对肿瘤存在、发病过程及预后作出判断。每個腫瘤標誌物對應的癌症有所不同。肿瘤标志物水平升高可能表明患有癌症,然而也可能有其他原因導致升高。
癌症标志物可回答的问题:
- 预后:这种癌症可能继续生长?
- 诊断:我患了何种癌症?
- 预测:这种药是针对我患癌症的最佳用药吗?
- 药效学:对我来说此药的最佳用量是多少?
- 复发:癌症会再次发作吗?
常見的腫瘤標誌物
腫瘤標誌物 | 有關的癌症 |
---|---|
Α-胎兒蛋白 (AFP) | 生殖细胞瘤, 肝細胞癌[2] |
CA 15-3 | 乳癌[3] |
CA27.29 | 乳癌[4] |
CA19-9 | 胰臟癌、大腸癌、胃肠道癌.[5] |
CA-125 | 卵巢癌,[6]、子宫内膜癌, 输卵管瘤, 肺癌, 乳癌和胃肠道癌.[7]、子宮內膜異位症.[8] |
降鈣素 | 甲狀腺髓質癌 |
Calretinin | 間皮瘤, 性腺间质肿瘤, adrenocortical carcinoma, 滑膜肉瘤[2] |
癌胚抗原 | 胃肠道癌, 子宮頸癌, 肺癌, 卵巢癌, 乳癌, urinary tract cancer[2] |
CD34 | hemangiopericytoma/solitary fibrous tumor, 多形性脂肪瘤, 胃腸道基質腫瘤, dermatofibrosarcoma protuberans[2] |
CD99MIC 2 | 尤文氏肉瘤, primitive neuroectodermal tumor, hemangiopericytoma/solitary fibrous tumor, 滑膜肉瘤, 淋巴瘤, 白血病, 性腺间质肿瘤[2] |
CD117 | 胃腸道基質腫瘤, mastocytosis, seminoma[2] |
Chromogranin | 神經內分泌腫瘤[2] |
Chromosomes 3, 7, 17, and 9p21 | 膀胱癌[9] |
Cytokeratin (TPA, TPS, Cyfra21-1) | 癌、肉瘤[2] |
Desmin | smooth muscle sarcoma, 横纹肌肉瘤, endometrial stromal sarcoma[2] |
Epithelial membrane antigen (EMA) | 癌、meningioma、肉瘤[2] |
Factor VIII, CD31 FL1 | vascular sarcoma[2] |
Glial fibrillary acidic protein (GFAP) | 神經膠質瘤 (astrocytoma, ependymoma)[2] |
Gross cystic disease fluid protein (GCDFP-15) | 乳癌, 卵巢癌, salivary gland cancer[2] |
hPG80 | 乳癌, 卵巢癌, 前列腺癌, 腎癌, 大腸癌, 肝癌 |
HMB-45 | 黑色素瘤, PEComa (例如 angiomyolipoma), clear cell adenocarcinoma, adrenocortical carcinoma[2] |
人绒毛膜促性腺激素 (hCG) | 妊娠滋养细胞疾病, 生殖细胞瘤, 绒毛膜癌[2] |
抗体 | 淋巴瘤, 白血病[2] |
激活素与抑制素 | 性腺间质肿瘤, adrenocortical carcinoma, hemangioblastoma[2] |
角蛋白 | 癌, 肉瘤[2] |
淋巴细胞 | 淋巴瘤, 白血病[2] |
MART-1 (Melan-A) | 黑色素瘤,adrenocortical carcinoma、gonadal tumor[2] |
Myo D1 | 横纹肌肉瘤, small, round, blue cell tumour[2] |
muscle-specific actin (MSA) | myosarcoma (平滑肌肉瘤, 横纹肌肉瘤)[2] |
neurofilament | 神經內分泌腫瘤, 小细胞癌[2] |
neuron-specific enolase (NSE) | 神經內分泌腫瘤, 小细胞癌, 乳癌[2] |
placental alkaline phosphatase (PLAP) | seminoma, 无性细胞瘤, 胚胎性癌[2] |
前列腺特异抗原 (PSA) | 前列腺[2] |
蛋白酪氨酸磷酸酶C型受體 (CD45) | 淋巴瘤, 白血病, histiocytic sarcoma[2] |
S100蛋白 | 黑色素瘤, 肉瘤 (neurosarcoma, 脂肪瘤, chondrosarcoma), astrocytoma, 胃腸道基質腫瘤, salivary gland cancer, adenocarcinoma, histiocytic tumor (樹突狀細胞, 巨噬细胞)[2] |
smooth muscle actin (SMA) | 胃腸道基質腫瘤, 平滑肌肉瘤, PEComa[2] |
突觸素 | 神經內分泌腫瘤[2] |
胸苷激酶 | 淋巴瘤, 白血病, 肺癌, 前列腺癌 |
thyroglobulin (Tg) | 甲狀腺癌[2] |
thyroid transcription factor-1 (TTF-1) | 甲狀腺癌, 肺癌[2] |
Tumor M2-PK | 大腸癌,[10] 乳癌,[11][12] renal cell carcinoma[13][14] 肺癌,[15][16] 胰臟癌,[17] 食道癌,[18] 胃癌,[18]子宮頸癌,[19] 卵巢癌,[20] |
波形蛋白 | 肉瘤, renal cell carcinoma, 子宫内膜癌, 肺癌, 淋巴瘤, 白血病, 黑色素瘤[2] |
分子癌症标志物
肿瘤类型 | 生物标志物 |
---|---|
乳腺 | ER(雌激素受体)[21][22] |
HER-2/neu[21][22] | |
结直肠 | EGFR[21][22] |
KRAS[21][23] | |
UGT1A1[21][23] | |
胃 | HER-2/neu[21] |
胃腸道基質腫瘤 | c-KIT[21][24] |
白血病/淋巴瘤 | CD20抗原[21][25] |
CD30[21][26] | |
FIP1L1-PDGRFα[21][27] | |
PDGFR[21][28] | |
费城染色体(BCR/ABL)[21][29][30] | |
PML/RARα[21][31] | |
TPMT[21][32] | |
UGT1A1[21][33] | |
肺 | ALK[21][34][35] |
EGFR[21][22] | |
KRAS[21][22] | |
黑色素瘤 | BRAF[21][35] |
生物标志物的其它例子:
参考文献
- . 瑞金医院. [2021-10-14]. (原始内容存档于2021-10-23).
- Page 746 (页面存档备份,存于) in: Title Manual of clinical oncology Spiral manual Manual of Clinical Oncology Lippincott Manual Series Authors Dennis Albert Casciato, Mary C. Territo Editors Dennis Albert Casciato, Mary C. Territo Contributor Mary C. Territo Edition 6, illustrated Publisher Lippincott Williams & Wilkins, 2008 ISBN 0-7817-6884-5, ISBN 978-0-7817-6884-9
- Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thurlimann, B; et al. . Annals of Oncology. 2006, 18 (4): 701–8. PMID 17237474. doi:10.1093/annonc/mdl492 .
- . [2021-10-14]. (原始内容存档于2014-02-25).
- gpnotebook.co.uk > ca-19-9 (页面存档备份,存于) Retrieved November 2011
- Osman N, O'Leary N, Mulcahy E, Barrett N, Wallis F, Hickey K, Gupta R. . Ir Med J. September 2008, 101 (8): 245–7. PMID 18990955.
- Bast RC, Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB. . Int. J. Biol. Markers. 1998, 13 (4): 179–87. PMID 10228898. doi:10.1177/172460089801300402.
- Bagan P, Berna P, Assouad J, Hupertan V, Le Pimpec Barthes F, Riquet M. . Eur. Respir. J. January 2008, 31 (1): 140–2. PMID 17804443. doi:10.1183/09031936.00094206 .
- . [June 6, 2013]. (原始内容存档于2015-02-25).
- Haug, U; Rothenbacher, D; Wente, M N; Seiler, C M; Stegmaier, C; Brenner, H. . British Journal of Cancer. 2007, 96 (9): 1329–34. PMC 2360192 . PMID 17406361. doi:10.1038/sj.bjc.6603712.
- Lüftner, D; Mesterharm, J; Akrivakis, C; Geppert, R; Petrides, PE; Wernecke, KD; Possinger, K. . Anticancer Research. 2000, 20 (6D): 5077–82. PMID 11326672.
- Benesch, C; Schneider, C; Voelker, HU; Kapp, M; Caffier, H; Krockenberger, M; Dietl, J; Kammerer, U; Schmidt, M. . Anticancer Research. 2010, 30 (5): 1689–94. PMID 20592362.
- Oremek, GM; Sapoutzis, N; Kramer, W; Bickeböller, R; Jonas, D. . Anticancer Research. 2000, 20 (6D): 5095–8. PMID 11326675.
- Wechsel, HW; Petri, E; Bichler, KH; Feil, G. . Anticancer Research. 1999, 19 (4A): 2583–90. PMID 10470199.
- Schneider, J; Peltri, G; Bitterlich, N; Philipp, M; Velcovsky, HG; Morr, H; Katz, N; Eigenbrodt, E. . Clinical and Experimental Medicine. 2003, 2 (4): 185–91. PMID 12624710. doi:10.1007/s102380300005.
- Oremek, G; Kukshaĭte, R; Sapoutzis, N; Ziolkovski, P. . Klinicheskaia Meditsina. 2007, 85 (7): 56–8. PMID 17882813.
- Hardt, PD; Ngoumou, BK; Rupp, J; Schnell-Kretschmer, H; Kloer, HU. . Anticancer Research. 2000, 20 (6D): 4965–8. PMID 11326648.
- Kumar, Yogesh; Tapuria, Niteen; Kirmani, Naveed; Davidson, Brian R. . European Journal of Gastroenterology & Hepatology. 2007, 19 (3): 265–276. PMID 17301655. doi:10.1097/MEG.0b013e3280102f78.
- Kaura, B; Bagga, R; Patel, FD. . The Journal of Obstetrics and Gynaecology Research. 2004, 30 (3): 193–6. PMID 15210041. doi:10.1111/j.1447-0756.2004.00187.x.
- Ahmed, AS; Dew, T; Lawton, FG; Papadopoulos, AJ; Devaja, O; Raju, KS; Sherwood, RA. . European Journal of Gynaecological Oncology. 2007, 28 (2): 83–8. PMID 17479666.
- . U.S Food and Drug Administration.
- (PDF). American Cancer Society. [2013-07-09]. (原始内容存档 (PDF)于2012-11-05).
- Lenz, Heinz-Josef. EdBk.GI.Colo.04.pdf 请检查
|url=
值 (帮助) (PDF). American Society of Clinical Oncology’s 2009 Educational Book. - Gonzalez RS, Carlson G, Page AJ, Cohen C. . Am. J. Clin. Pathol. July 2011, 136 (1): 74–80. PMID 21685034. doi:10.1309/AJCP9KHD7DCHWLMO.
- Tam CS, Otero-Palacios J, Abruzzo LV; et al. . Br. J. Haematol. April 2008, 141 (1): 36–40. PMID 18324964. doi:10.1111/j.1365-2141.2008.07012.x.
- Zhang M, Yao Z, Patel H; et al. . Proc. Natl. Acad. Sci. U.S.A. May 2007, 104 (20): 8444–8. PMC 1895969 . PMID 17488826. doi:10.1073/pnas.0702496104.
- Yamada Y, Sanchez-Aguilera A, Brandt EB; et al. . Blood. September 2008, 112 (6): 2500–7. PMID 18539901. doi:10.1182/blood-2007-11-126268.
- Nimer SD. . Blood. May 2008, 111 (10): 4841–51. PMID 18467609. doi:10.1182/blood-2007-08-078139.
- Ottmann O, Dombret H, Martinelli G; et al. . Blood. October 2007, 110 (7): 2309–15. PMID 17496201. doi:10.1182/blood-2007-02-073528.
- Boulos N, Mulder HL, Calabrese CR; et al. . Blood. March 2011, 117 (13): 3585–95. PMC 3072880 . PMID 21263154. doi:10.1182/blood-2010-08-301267.
- O'Connell PA, Madureira PA, Berman JN, Liwski RS, Waisman DM. . Blood. April 2011, 117 (15): 4095–105. PMID 21310922. doi:10.1182/blood-2010-07-298851.
- Duffy MJ, Crown J. . Clin. Chem. November 2008, 54 (11): 1770–9. PMID 18801934. doi:10.1373/clinchem.2008.110056.
- Ribrag V, Koscielny S, Casasnovas O; et al. . Blood. April 2009, 113 (14): 3307–13. PMID 18768784. doi:10.1182/blood-2008-03-148874.
- Li Y, Ye X, Liu J, Zha J, Pei L. . Neoplasia. January 2011, 13 (1): 1–11. PMC 3022423 . PMID 21245935.
- Pao W, Girard N. . Lancet Oncol. February 2011, 12 (2): 175–80 [2013-07-09]. PMID 21277552. doi:10.1016/S1470-2045(10)70087-5. (原始内容存档于2020-08-09).
- Bartels CL, Tsongalis GJ. . Clin. Chem. April 2009, 55 (4): 623–31. PMID 19246618. doi:10.1373/clinchem.2008.112805.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.